radiotherapy

Oncology

Are radiopharmaceuticals the next breakthrough in oncology?

Ben Hargreaves examines what advantages radiopharmaceuticals offer in the treatment of cancer and why there has been interest from big pharma in developing these types of therapies.

Events

Partner Content

Targeted Radiopharmaceuticals Summit US (TRP US)

The inaugural Targeted Radiopharmaceuticals Summit US will bring together a worldwide community of specialists to address long-standing challenges in radiopharmac

News

Elekta to work with academics on AI-directed radiotherapy

Radiotherapy specialist Elekta has joined forces with two academic groups in the Netherlands to explore the use of artificial intelligence (AI) to deliver more effective personalised therap

News

TAE raises $40m to develop new targeted radiotherapy

Medtech firm TAE Life Sciences is developing a ground-breaking radiotherapy technology which will be able to treat hard-to-reach cancers with targeted beams.

Are radiopharmaceuticals the next breakthrough in oncology?

Targeted Radiopharmaceuticals Summit US (TRP US)

Elekta to work with academics on AI-directed radiotherapy

TAE raises $40m to develop new targeted radiotherapy

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

radiotherapy

Editor's Picks